| 31 December | |||||
| 2024 | 31 December | ||||
| Before | 2024 | ||||
| 31 December | exceptional | Exceptional | 31 December | ||
| 2025 | items | items 1 | 2024 | ||
| Note | £m | £m | £m | £m | |
Transaction fees | |||||
Servicing fees | |||||
Interest income 2 | |||||
Other fees | |||||
Operating income | |||||
Investment income | |||||
Total income | |||||
Fair value (losses)/gains | ( | ||||
Cost of funds | ( | ( | ( | ||
Net income 3 | 5 | ||||
Expected credit loss charge | 2, 15, 16, 27 | ( | ( | ( | |
People costs | 4, 6, 7 | ( | ( | ( | ( |
Marketing costs | 6 | ( | ( | ( | |
Depreciation, amortisation and impairment | 4, 5, 6, 10, 11 | ( | ( | ( | ( |
Other costs | 6 | ( | ( | ( | |
Operating expenses | 6 | ( | ( | ( | ( |
Profit/(loss) before taxation | 5 | ( | |||
Income tax credit/(charge) | 8 | ( | ( | ||
Profit/(loss) for the year from continuing operations | ( | ||||
(Loss)/profit for the year from discontinued operations | 3 | ( | |||
Profit/(loss) for the year | ( | ||||
| Other comprehensive expense | |||||
| Items that may be reclassified subsequently to profit and loss: | |||||
| Exchange differences on translation of foreign operations | 3, 19 | ( | ( | ( | |
| – discontinued operations | |||||
Total comprehensive income/(expense) for the year | ( | ( | |||
| Total comprehensive income/(expense) attributable to: | |||||
| Owners of the Parent | |||||
Income/(expense) from continuing operations | ( | ||||
(Expense)/income from discontinued operations | 3 | ( | ( | ||
Total comprehensive income/(expense) attributable to the owners of the Parent | ( | ( | |||
| Earnings per share | |||||
Basic earnings per share from continuing operations | 9 | ||||
Diluted earnings per share from continuing operations | 9 | ||||
Basic (loss)/earnings per share from discontinued operations | 3, 9 | ( | |||
Diluted (loss)/earnings per share from discontinued operations | 3, 9 | ( | |||
Basic total earnings/(loss) per share from all operations | 3, 9 | ( | |||
Diluted total earnings/(loss) per share from all operations | 3, 9 | ( |
| 31 December | 31 December | ||
| 2025 | 2024 | ||
| Note | £m | £m | |
| Non-current assets | |||
Intangible assets | 10 | ||
Property, plant and equipment | 11 | ||
Investment in associates | 29 | ||
Investment in trusts and co‑investments | 12, 16 | ||
Deferred tax asset | 8 | ||
SME loans held at amortised cost | 12, 16 | ||
| Current assets | |||
SME loans held at amortised cost | 12, 16 | ||
SME loans held at fair value through profit and loss | 12, 16 | ||
Lines of credit | 12, 16 | ||
Trade and other receivables | 13 | ||
Cash and cash equivalents | 22 | ||
Total assets | |||
| Current liabilities | |||
Trade and other payables | 14 | ||
Bank borrowings | 16, 22 | ||
Short‑term provisions and other liabilities | 15 | ||
Lease liabilities | 11, 22 | ||
| Non-current liabilities | |||
Long‑term provisions and other liabilities | 15 | ||
Lease liabilities | 11, 22 | ||
Total liabilities | |||
| Equity | |||
Share capital | 17 | ||
Share premium account | 18 | ||
Foreign exchange reserve | 19 | ||
Share options reserve | |||
Retained earnings | 20 | ||
Total equity | |||
Total equity and liabilities |
| Retained | |||||||
| Share | Foreign | Share | earnings/ | ||||
| Share | premium | exchange | options | (accumulated | Total | ||
| capital | account | reserve | reserve | losses) | equity | ||
| Note | £m | £m | £m | £m | £m | £m | |
Balance at 1 January 2024 | ( | ||||||
Profit for the year | 20 | ||||||
| Other comprehensive expense | |||||||
| Exchange differences on translation | 19 | ( | ( | ||||
| of foreign operations | |||||||
Total comprehensive (expense)/income | ( | ( | |||||
| Transactions with owners | |||||||
Transfer of share option costs | 20 | ( | |||||
Buyback of own shares | 17, 20 | ( | ( | ( | |||
Capital reduction | 18, 20 | ( | |||||
| Issue of share capital/exercise | 18 | ||||||
| of share options | |||||||
| Employee share schemes – | 21 | ||||||
| value of employee services | |||||||
Balance at 31 December 2024 | |||||||
Profit for the year | 20 | ||||||
| Other comprehensive income | |||||||
| Exchange differences on translation | 19 | ||||||
| of foreign operations | |||||||
Total comprehensive income | |||||||
| Transactions with owners | |||||||
Transfer of share option costs | 20 | ( | |||||
Buyback of own shares | 17, 20 | ( | ( | ||||
| Purchase of own shares by Employee | 17, 20 | ( | ( | ||||
| Benefit Trust (“EBT”) | |||||||
| Issue of share capital/exercise | 18 | ||||||
| of share options | |||||||
| Employee share schemes – | 21 | ||||||
| value of employee services | |||||||
Balance at |
| 31 December | 31 December | ||
| 2025 | 2024 | ||
| Note | £m | £m | |
Net cash outflow from operating activities | 22 | ( | ( |
| Investing activities | |||
Purchase of intangible assets | 10 | ( | ( |
Purchase of property, plant and equipment | 11 | ( | ( |
Originations/purchase of SME loans held at amortised cost | 16 | ( | ( |
Proceeds from sale of SME loans held at amortised cost | 16 | ||
Cash receipts from SME loans held at amortised cost | 16 | ||
Originations/purchase of SME loans held at fair value through profit and loss | 16 | ( | |
Cash receipts from SME loans held at fair value through profit and loss | 16 | ||
Proceeds from sale of SME loans held at fair value through profit and loss | 16 | ||
Investment in trusts and co‑investments | 16 | ( | ( |
Cash receipts from investments in trusts and co‑investments | 16 | ||
Redemption in associates | 25, 29 | ||
Proceeds from sale of subsidiary | 3 | ||
Direct costs of selling subsidiary | 3 | ( | |
Cash disposed of on sale of subsidiary | 3 | ( | |
Net cash (outflow)/inflow from investing activities | ( | ||
| Financing activities | |||
Proceeds from bank borrowings | 22 | ||
Repayment of bank borrowings | 22 | ( | ( |
Proceeds from the exercise of share options | 18 | ||
Purchase of own shares by EBT | 17, 20 | ( | |
Buyback of own shares | 17, 20 | ( | ( |
Proceeds from subleases | |||
Payment of lease liabilities | 22 | ( | ( |
Net cash inflow from financing activities | |||
Net decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at the beginning of the year | |||
Effect of foreign exchange rate changes | |||
Cash and cash equivalents at the end of the year | 22 |
| Applicable for | ||
| financial years | ||
| beginning | ||
Standard/interpretation | Content | on/after |
| Amendments to IAS 21 – Lack of | Foreign | 1 January |
| Exchangeability | exchange | 2025 |
| rates |
| Applicable for | ||
| financial years | ||
| beginning | ||
Standard/interpretation | Content | on/after |
| Amendment to IFRS 9 and IFRS 7 | Financial | 1 January |
| – Classification and Measurement | instruments | 2026 |
| of Financial Instruments | ||
| IFRS 18 Presentation and | Financial | 1 January |
| Disclosure in Financial Statements | statements | 2027 |
| disclosures | ||
| IFRS 19 Subsidiaries without | Financial | 1 January |
| Public Accountability: Disclosures | statements | 2027 |
| disclosures |
| Change in | ||||||
| average PD | Change in | |||||
| compared | ECL compared | |||||
| Scenario | to blended | to blended | ||||
| weighting | 100% weighting | Average PD | ECL | scenario | scenario | |
| ECL scenario | % | to scenario | % | £ | % | £ |
Base case | 70% | 100% | 8.8% | 34.5 | (0.2)% | (0.2) |
Upside | 15% | 100% | 6.0% | 29.6 | (3.0)% | (5.1) |
Downside | 15% | 100% | 12.4% | 40.9 | 3.4% | 6.2 |
Blended weighted scenarios | 100% | 100% | 9.0% | 34.7 | — | — |
| Fair value | Relationship of | |||
| Description | £m | Unobservable input | Inputs | unobservable inputs to fair value |
Shorter-term loans | 120.4 | Lifetime cumulative default | 16.6% | A change in the lifetime cumulative default |
| rate as % of original | rate by +590/-470 bps would decrease/ | |||
| increase fair value by £(11.2) million/ | ||||
| £8.5 million respectively. |
| Fair value | Relationship of | |||
| Description | £m | Unobservable input | Inputs | unobservable inputs to fair value |
Shorter-term loans | 120.4 | Risk-adjusted discount rate | 22.4% | A change in the discount rates by +/-200 |
| bps would decrease/increase fair value by | ||||
| £(1.2) million/£1.2 million respectively. |
| Before | 31 December | |||
| exceptional | Exceptional | 2024 | ||
| Note | items | items | £m | |
Transaction fees | 10.3 | — | 10.3 | |
Servicing fees | 2.1 | — | 2.1 | |
Interest income | 0.7 | — | 0.7 | |
Other fees | 0.2 | — | 0.2 | |
Operating income | 13.3 | — | 13.3 | |
Investment income | 0.7 | — | 0.7 | |
Total income | 14.0 | — | 14.0 | |
Fair value gains | 2.2 | — | 2.2 | |
Net income | 16.2 | — | 16.2 | |
Expected credit loss charge | 15, 16 | (0.1) | — | (0.1) |
People costs | (16.0) | 1.7 | (14.3) | |
Marketing costs | (3.7) | — | (3.7) | |
Depreciation, amortisation, impairment and modification gains | 10, 11 | (0.3) | — | (0.3) |
Other costs | (6.2) | — | (6.2) | |
Operating expenses | (26.2) | 1.7 | (24.5) | |
Realised FX recycled from foreign currency translation | — | 8.7 | 8.7 | |
Gain on disposal of US business | — | 8.1 | 8.1 | |
(Loss)/profit before taxation | (10.1) | 18.5 | 8.4 | |
Income tax | 8 | (0.1) | — | (0.1) |
(Loss)/profit for the year from discontinued operations | (10.2) | 18.5 | 8.3 | |
| Other comprehensive expense | ||||
| Exchange differences on translation of foreign operations – | 19 | (0.2) | (8.7) | (8.9) |
| discontinued operations | ||||
Total comprehensive (expense)/income for the year attributable to owners of the Parent | (10.4) | 9.8 | (0.6) | |
| Earnings per share | ||||
Basic (loss)/earnings per share from discontinued operations | 9 | (3.0)p | 2.4p | |
Diluted (loss)/earnings per share from discontinued operations | 9 | (3.0)p | 2.2p |
| 31 December | |
| 2024 | |
| £m | |
Profit before tax | 8.4 |
Depreciation, amortisation impairment and modification gains | (0.3) |
Exceptional items | 18.5 |
Expected credit loss credit/(charge) | (0.1) |
| 31 December | |
| 2024 | |
| £m | |
Cash and cash equivalents at the beginning of the year | 22.3 |
Net cash outflow from operating activities | (8.6) |
Net cash outflow from investing activities | (13.3) |
Net cash outflow from financing activities | (0.6) |
Net decrease in cash generated | (0.2) |
Effect of foreign exchange rate changes | 0.2 |
Cash and cash equivalents at the end of the year | — |
| 31 December | |
| 2024 | |
| £m | |
| Consideration received: | |
Cash consideration at prevailing exchange rate | 32.6 |
Net assets disposed of (including cash and cash equivalents of £23.1 million) | (22.2) |
Gross gain on sale | 10.4 |
Direct transaction costs for legal, advisory and other costs | (2.3) |
Net impact of (early vesting)/lapsing US share options | 1.7 |
Other disposal-related costs | (0.6) |
Gain on sale | 9.8 |
Reclassification of foreign currency translation reserve | 8.7 |
Total gain as a result of disposal after reclassification of foreign currency translation reserve | 18.5 |
| 31 December | |
| 2024 | |
| £m | |
| Non-current assets | |
Property, plant and equipment | 0.3 |
Investment in trusts and co-investments | 0.7 |
SME loans held at amortised cost | 1.9 |
Trade and other receivables | 1.0 |
| 3.9 | |
| Current assets | |
SME loans held at fair value through profit and loss | 5.9 |
Trade and other receivables | 3.1 |
Cash and cash equivalents | 23.1 |
| 32.1 | |
Total assets | 36.0 |
| Current liabilities | |
Trade and other payables | 4.7 |
Lease liabilities | 3.6 |
| 8.3 | |
| Non-current liabilities | |
Bank borrowings | 1.6 |
Lease liabilities | 3.9 |
| 5.5 | |
Total liabilities | 13.8 |
Total net assets | 22.2 |
31 December 2025 | 31 December 2024 1 | |||||
Continuing operations | Continuing operations | |||||
| Term Loans | FlexiPay | Total | Term Loans | FlexiPay | Total | |
| £m | £m | £m | £m | £m | £m | |
Transaction fees | 105.8 | 1.2 | 107.0 | 84.7 | 0.6 | 85.3 |
Servicing fees | 35.9 | — | 35.9 | 37.5 | — | 37.5 |
Interest income | 5.6 | 44.6 | 50.2 | 8.3 | 22.6 | 30.9 |
Other fees | 5.0 | 0.1 | 5.1 | 5.1 | 0.1 | 5.2 |
Operating income | 152.3 | 45.9 | 198.2 | 135.6 | 23.3 | 158.9 |
Investment income | 24.3 | — | 24.3 | 2.8 | — | 2.8 |
Total income | 176.6 | 45.9 | 222.5 | 138.4 | 23.3 | 161.7 |
Fair value (losses)/gains | (6.7) | — | (6.7) | 4.2 | — | 4.2 |
Cost of funds | (2.5) | (9.0) | (11.5) | — | (5.8) | (5.8) |
Net income (“revenue”) | 167.4 | 36.9 | 204.3 | 142.6 | 17.5 | 160.1 |
Profit/(loss) before tax | 32.2 | (11.9) | 20.3 | 16.7 | (15.9) | 0.8 |
| Depreciation, amortisation impairment and modification gains | (8.5) | (2.6) | (11.1) | (11.4) | (1.8) | (13.2) |
Exceptional items | — | — | — | (2.3) | (0.3) | (2.6) |
Expected credit loss credit/(charge) | 0.9 | (19.2) | (18.3) | 0.2 | (8.8) | (8.6) |
| Before | |||||
| 31 December | exceptional | Exceptional | 31 December | ||
| 2025 | items | items 1 | 2024 | ||
| Note | £m | £m | £m | £m | |
| Continuing operations | |||||
Depreciation | 11 | 2.3 | 3.0 | — | 3.0 |
Amortisation | 10 | 8.7 | 9.8 | — | 9.8 |
Impairment of intangibles | 4, 10 | 0.1 | 0.8 | 0.3 | 1.1 |
Modification gains | 11 | — | (0.4) | — | (0.4) |
Employment costs (including contractors) | 4, 7 | 68.4 | 68.1 | 2.3 | 70.4 |
Marketing costs (excluding employment costs) | 62.0 | 45.6 | — | 45.6 | |
Data and technology | 8.0 | 7.2 | — | 7.2 | |
Other expenses | 16.2 | 14.0 | — | 14.0 | |
Total operating expenses from continuing operations | 165.7 | 148.1 | 2.6 | 150.7 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
| Audit fees | ||
| Continuing operations | ||
– Fees payable to the Company’s auditors for the audit of the Parent Company and consolidated financial statements | 0.4 | 0.4 |
– Fees payable to the Company’s auditors and its associates for the statutory audit of the financial statements of subsidiaries of the Company | 0.6 | 0.5 |
Total audit fees | 1.0 | 0.9 |
| Non-audit service fees | ||
– Audit-related assurance services | 0.3 | 0.3 |
– Other assurance services | 0.1 | 0.1 |
Total non-audit service fees | 0.4 | 0.4 |
| 2025 | 2024 | |
| Number | Number | |
| Continuing operations | ||
Term Loans | 600 | 628 |
FlexiPay | 83 | 88 |
Other | 2 | 5 |
Total continuing operations | 685 | 721 |
Discontinued operations 1 | ||
US | — | 106 |
Total discontinued operations | — | 106 |
Total | 685 | 827 |
| 31 December | 31 December | |||
| 2025 | 2024 | |||
| Before | ||||
| exceptional | Exceptional | |||
| Total | items | items ¹ | Total | |
| Continuing operations | £m | £m | £m | £m |
Wages and salaries | 57.4 | 56.0 | — | 56.0 |
Social security costs | 7.1 | 6.3 | — | 6.3 |
Pension costs | 2.1 | 2.1 | — | 2.1 |
Share-based payments | 5.9 | 7.8 | — | 7.8 |
Exceptional costs | — | — | 2.3 | 2.3 |
72.5 | 72.2 | 2.3 | 74.5 | |
Contractor costs | 4.7 | 4.9 | — | 4.9 |
Less: capitalised development costs | (8.8) | (9.0) | — | (9.0) |
Employment costs net of capitalised development costs | 68.4 | 68.1 | 2.3 | 70.4 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
| Current tax | ||
| Continuing operations | ||
| UK | ||
Current tax on profits/(losses) for the year | 0.4 | 0.5 |
0.4 | 0.5 | |
Total current tax charge from continuing operations | 0.4 | 0.5 |
| Discontinued operations | ||
| US | ||
Current tax on (losses)/profits for the year | — | 0.1 |
Adjustment in respect of prior years | — | — |
Total current tax charge from discontinued operations | — | 0.1 |
Total current tax charge | 0.4 | 0.6 |
| Deferred tax | ||
| Continuing operations | ||
| UK | ||
Deferred tax on profits/(losses) for the year | (26.1) | — |
(26.1) | — | |
Total deferred tax credit from continuing operations | (26.1) | — |
Total deferred tax credit | (26.1) | — |
Total tax (credit)/charge | (25.7) | 0.6 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Profit before taxation for the Group | 20.3 | 9.2 |
Taxation on profit at 25.0% (2024: 25.0%) | 5.1 | 2.3 |
| Effects of: | ||
Research and development | — | 0.4 |
Foreign tax rates | — | 0.1 |
Non-taxable/non-deductible expenses | — | 0.3 |
Unrecognised timing differences | 0.2 | (0.1) |
Unrecognised tax losses accumulated | 0.4 | 1.1 |
Deferred tax assets recognised | (26.1) | — |
Patent box | (5.3) | — |
Impairment charge | — | (3.5) |
Total tax (credit)/charge | (25.7) | 0.6 |
Total tax (credit)/charge from continuing operations | (25.7) | 0.5 |
Total tax charge from discontinued operations | — | 0.1 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Carry forward losses (UK) | 23.6 | — |
RDEC Step 2 credits | 2.5 | — |
Recognised deferred tax | 26.1 | — |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Property, plant and equipment | 8.5 | 6.9 |
Carry forward losses | 34.5 | 125.0 |
Deferred stock options | 22.7 | 22.5 |
RDEC Step 2 credits | — | 8.0 |
Other | 0.6 | 0.2 |
Unrecognised deferred tax 1 | 66.3 | 162.6 |
| 31 December | |||
| 2024 | |||
| 31 December | 31 December | Before | |
| 2025 | 2024 | exceptional | |
| Total | Total | items | |
| Earnings per share from continuing operations | £m | £m | £m |
Profit for the year from continuing operations | 46.0 | 0.3 | 2.9 |
Basic weighted average number of ordinary shares in issue (million) | 314.6 | 342.4 | 342.4 |
Basic earnings per share from continuing operations | 14.6p | 0.1p | 0.8p |
Profit for the year from continuing operations | 46.0 | 0.3 | 2.9 |
Diluted weighted average number of ordinary shares in issue (million) | 328.6 | 382.2 | 382.2 |
Diluted earnings per share from continuing operations | 14.0p | 0.1p | 0.8p |
| 31 December | |||
| 2024 | |||
| 31 December | 31 December | Before | |
| 2025 | 2024 | exceptional | |
| Total | Total | items | |
| Earnings/(loss) per share from discontinued operations | £m | £m | £m |
Profit/(loss) for the year from discontinued operations | — | 8.3 | (10.2) |
Basic weighted average number of ordinary shares in issue (million) | 314.6 | 342.4 | 342.4 |
Basic earnings/(loss) per share from discontinued operations | — | 2.4p | (3.0)p |
Profit/(loss) for the year from discontinued operations | — | 8.3 | (10.2) |
Diluted weighted average number of ordinary shares in issue (million) | 328.6 | 382.2 | 342.4 |
Diluted earnings/(loss) per share from discontinued operations | — | 2.2p | (3.0)p |
| 31 December | |||
| 2024 | |||
| 31 December | 31 December | Before | |
| 2025 | 2024 | exceptional | |
| Total | Total | items | |
| Earnings/(loss) per share from all operations | £m | £m | £m |
Profit/(loss) for the year | 46.0 | 8.6 | (7.3) |
Basic weighted average number of ordinary shares in issue (million) | 314.6 | 342.4 | 342.4 |
Basic total earnings/(loss) per share | 14.6p | 2.5p | (2.1)p |
Profit/(loss) for the year | 46.0 | 8.6 | (7.3) |
Diluted weighted average number of ordinary shares in issue (million) | 328.6 | 382.2 | 342.4 |
Diluted total earnings/(loss) per share | 14.0p | 2.3p | (2.1)p |
| 31 December | ||
| 2024 | ||
| 31 December | Before | |
| 2025 | exceptional | |
| Adjusted | items | |
| Total | Total | |
| Adjusted earnings per share from continuing operations | £m | £m |
Profit for the year from continuing operations | 46.0 | 0.3 |
Less impact of deferred tax | (26.1) | — |
Less exceptional items | — | 2.6 |
Adjusted profit for the year from continuing operations | 19.9 | 2.9 |
Basic weighted average number of ordinary shares in issue (million) | 314.6 | 342.4 |
Basic adjusted earnings per share from continuing operations | 6.3p | 0.8p |
Profit for the year from continuing operations | 46.0 | 0.3 |
Less impact of deferred tax | (26.1) | — |
Less exceptional items | — | 2.6 |
Adjusted profit for the year from continuing operations | 19.9 | 2.9 |
Diluted weighted average number of ordinary shares in issue (million) | 328.6 | 382.2 |
Diluted adjusted total earnings per share from continuing operations | 6.1p | 0.8p |
| Capitalised | ||||
| development | Computer | Other | ||
| costs | software | intangibles | Total | |
| £m | £m | £m | £m | |
| Cost | ||||
At 1 January 2024 | 61.2 | 0.4 | 1.2 | 62.8 |
Exchange differences | 0.2 | — | (0.1) | 0.1 |
Additions | 9.0 | — | — | 9.0 |
Disposals | (4.4) | (0.3) | — | (4.7) |
Derecognition of assets of discontinued operations | (15.7) | — | — | (15.7) |
At 31 December 2024 | 50.3 | 0.1 | 1.1 | 51.5 |
At 1 January 2025 | 50.3 | 0.1 | 1.1 | 51.5 |
Exchange differences | — | — | 0.1 | 0.1 |
Additions | 8.8 | 0.1 | — | 8.9 |
Disposals | (3.4) | — | — | (3.4) |
Derecognition of assets of discontinued operations | — | — | — | — |
At 31 December 2025 | 55.7 | 0.2 | 1.2 | 57.1 |
| Accumulated amortisation | ||||
At 1 January 2024 | 38.4 | 0.2 | 1.2 | 39.8 |
Exchange differences | 0.1 | — | (0.1) | — |
Charge for the year | 9.7 | 0.1 | — | 9.8 |
Impairment (exceptional item) | 0.3 | — | — | 0.3 |
Impairment | 0.7 | 0.1 | — | 0.8 |
Disposals | (4.4) | (0.3) | — | (4.7) |
Derecognition of assets of discontinued operations | (15.7) | — | — | (15.7) |
At 31 December 2024 | 29.1 | 0.1 | 1.1 | 30.3 |
At | 29.1 | 0.1 | 1.1 | 30.3 |
Exchange differences | — | — | 0.1 | 0.1 |
Charge for the year | 8.7 | — | — | 8.7 |
Impairment | 0.1 | — | — | 0.1 |
Disposals | (3.4) | — | — | (3.4) |
At 31 December 2025 | 34.5 | 0.1 | 1.2 | 35.8 |
| Carrying amount | ||||
At 31 December 2025 | 21.2 | 0.1 | — | 21.3 |
At 31 December 2024 | 21.2 | — | — | 21.2 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Property, plant and equipment (owned) | 2.5 | 2.9 |
Right-of-use assets | 5.4 | 6.7 |
7.9 | 9.6 |
| Right-of-use | |||||
| Leasehold | Computer | Furniture and | assets | ||
| improvements | equipment | fixtures | (property) | Total | |
| £m | £m | £m | £m | £m | |
| Cost | |||||
At 1 January 2024 | 5.2 | 2.6 | 2.1 | 32.3 | 42.2 |
Disposals | (3.7) | (0.4) | (0.7) | (9.6) | (14.4) |
Lease modification | — | — | — | 5.7 | 5.7 |
Additions | 2.3 | 0.5 | 0.1 | — | 2.9 |
| Exchange differences and other non-cash | (0.4) | — | — | 0.1 | (0.3) |
| movements | |||||
Derecognition of assets of discontinued operations | (0.2) | (1.0) | (0.7) | (10.2) | (12.1) |
At 31 December 2024 | 3.2 | 1.7 | 0.8 | 18.3 | 24.0 |
At 1 January 2025 | 3.2 | 1.7 | 0.8 | 18.3 | 24.0 |
Disposals | — | (0.5) | (0.1) | — | (0.6) |
Additions | 0.3 | 0.3 | — | — | 0.6 |
At 31 December 2025 | 3.5 | 1.5 | 0.7 | 18.3 | 24.0 |
| Accumulated depreciation | |||||
At 1 January 2024 | 4.5 | 1.7 | 2.0 | 29.0 | 37.2 |
Disposals | (3.7) | (0.4) | (0.7) | (9.6) | (14.4) |
Charge for the year | 0.5 | 0.6 | 0.1 | 2.0 | 3.2 |
Impairment | — | 0.1 | — | — | 0.1 |
Exchange differences | — | — | — | 0.1 | 0.1 |
Derecognition of assets of discontinued operations | (0.2) | (1.0) | (0.7) | (9.9) | (11.8) |
At 31 December 2024 | 1.1 | 1.0 | 0.7 | 11.6 | 14.4 |
At 1 January 2025 | 1.1 | 1.0 | 0.7 | 11.6 | 14.4 |
Disposals | — | (0.5) | (0.1) | — | (0.6) |
Charge for the year | 0.5 | 0.5 | — | 1.3 | 2.3 |
At 31 December 2025 | 1.6 | 1.0 | 0.6 | 12.9 | 16.1 |
| Carrying amount | |||||
At 31 December 2025 | 1.9 | 0.5 | 0.1 | 5.4 | 7.9 |
At 31 December 2024 | 2.1 | 0.7 | 0.1 | 6.7 | 9.6 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Current | 1.8 | 1.8 |
Non-current | 4.5 | 5.8 |
Total | 6.3 | 7.6 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| Continuing operations | £m | £m |
Depreciation charge of right-of-use assets (property) | 1.3 | 1.9 |
Gain on modification of lease liability | — | (0.4) |
Interest expense (included in operating expenses) | 0.6 | 0.6 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
| Non-current | ||
SME loans – amortised cost | 1.2 | 1.4 |
Investment in trusts and co-investments – FVTPL | 11.9 | 17. 8 |
Total non-current | 13.1 | 19.2 |
| Current | ||
SME loans – amortised cost | 0.9 | 0.7 |
Lines of credit – amortised cost 1 | 172.9 | 97.1 |
SME loans – FVTPL | 120.8 | 1.2 |
Total current | 294.6 | 99.0 |
Total | 307.7 | 118.2 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Trade receivables | 0.2 | 0.4 |
Other receivables | 6.7 | 4.2 |
Tax-related receivables | 3.7 | 4.8 |
Prepayments | 4.7 | 4.7 |
Accrued income | 4.3 | 5.8 |
Rent and other deposits | 0.9 | 0.9 |
Current trade and other receivables | 20.5 | 20.8 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Trade payables | 0.8 | 1.8 |
Other taxes and social security costs | 7.5 | 7.0 |
Other creditors 1 | 5.9 | 6.5 |
Accruals and deferred income | 16.6 | 12.5 |
30.8 | 27.8 |
| ECL on | |||||
| undrawn | |||||
| Loan | lines of credit | ||||
| Dilapidation | repurchase | Restructuring 1 | and other 2 | Total | |
| £m | £m | £m | £m | £m | |
At 1 January 2024 | 1.1 | 0.1 | — | 1.4 | 2.6 |
Additional provision/liability | — | — | 2.3 | 2.2 | 4.5 |
Amount utilised | (0.3) | (0.1) | (2.3) | — | (2.7) |
Amount reversed | (0.2) | — | — | — | (0.2) |
At 31 December 2024 | 0.6 | — | — | 3.6 | 4.2 |
Additional provision/liability | — | — | — | — | — |
Amount utilised | — | — | — | (0.9) | (0.9) |
Amount reversed | — | — | — | (0.2) | (0.2) |
At 31 December 2025 | 0.6 | — | — | 2.5 | 3.1 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Current provisions and other liabilities | 2.5 | 3.6 |
Non-current provisions and other liabilities | 0.6 | 0.6 |
3.1 | 4.2 |
31 December 2025 | 31 December 2024 | |||||
| Fair value | Fair value | |||||
| through | through | |||||
| profit | Amortised | profit | Amortised | |||
| and loss | cost | Total | and loss | cost | Total | |
| £m | £m | £m | £m | £m | £m | |
| Assets | ||||||
SME loans held at amortised cost | — | 2.1 | 2.1 | — | 2.1 | 2.1 |
SME loans held at fair value through profit and loss | 120.8 | — | 120.8 | 1.2 | — | 1.2 |
Lines of credit | — | 172.9 | 172.9 | — | 97.1 | 97.1 |
Investment in trusts and co-investments | 11.9 | — | 11.9 | 1 7.8 | — | 17. 8 |
Trade and other receivables 1 | 0.3 | 11.8 | 12.1 | 0.6 | 10.7 | 11.3 |
Cash and cash equivalents 1 | 84.8 | 67.6 | 152.4 | 136.3 | 51.3 | 187.6 |
217.8 | 254.4 | 472.2 | 155.9 | 161.2 | 317.1 | |
| Liabilities | ||||||
Trade and other payables | — | (6.7) | (6.7) | — | (8.3) | (8.3) |
Bank borrowings | — | (267.3) | (267.3) | — | (101.9) | (101.9) |
Lease liabilities | — | (6.3) | (6.3) | — | (7.6) | (7.6) |
— | (280.3) | (280.3) | — | (117.8) | (117.8) |
| Fair value measurement using | ||||||
31 December 2025 | 31 December 2024 | |||||
| Quoted | Quoted | |||||
| prices | Significant | Significant | prices | Significant | Significant | |
| in active | observable | unobservable | in active | observable | unobservable | |
| markets | inputs | inputs | markets | inputs | inputs | |
| (level 1) | (level 2) | (level 3) | (level 1) | (level 2) | (level 3) | |
| £m | £m | £m | £m | £m | £m | |
| Financial assets | ||||||
| SME loans held at fair value through profit | — | — | 120.8 | — | — | 1.2 |
| and loss | ||||||
Trade and other receivables | 0.3 | — | — | 0.6 | — | — |
Investment in trusts and co-investments | — | — | 11.9 | — | — | 17. 8 |
Cash and cash equivalents | 84.8 | — | — | 136.3 | — | — |
85.1 | — | 132.7 | 136.9 | — | 19.0 |
| SME loans | ||
| held at fair | Investment in | |
| value through | trusts and | |
| profit and loss | co-investments | |
| £m | £m | |
Balance at 1 January 2024 | 18.6 | 25.2 |
Additions | — | 4.1 |
Repayments | (13.5) | (14.6) |
Net gain on the change in fair value of financial instruments at fair value through profit or loss | 2.6 | 3.8 |
Other non-cash movements | (0.7) | — |
Disposal of discontinued operations | (5.8) | (0.7) |
Balance at 31 December 2024 | 1.2 | 17.8 |
Additions | 180.6 | 0.8 |
Repayments | (51.8) | (8.2) |
Accrual of interest | 2.9 | — |
Net (loss)/gain on the change in fair value of financial instruments at fair value through profit or loss | (8.2) | 1.5 |
Sale of loans | (3.9) | — |
Balance at 31 December 2025 | 120.8 | 11.9 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
| Non-current | ||
SME loans held at amortised cost | 1.2 | 1.4 |
Investment in trusts and co-investments | 11.9 | 17.8 |
| Current | ||
SME loans held at amortised cost | 0.9 | 0.7 |
SME loans held at fair value through profit and loss | 120.8 | 1.2 |
Lines of credit | 172.9 | 97.1 |
| Trade and other receivables: | ||
– Trade receivables | 0.2 | 0.4 |
– Other receivables | 6.7 | 4.2 |
– Accrued income | 4.3 | 5.8 |
– Rent and other deposits | 0.9 | 0.9 |
Cash and cash equivalents | 152.4 | 187.6 |
Total gross credit risk exposure | 472.2 | 317.1 |
Less bank borrowings 1 | (267.3) | (101.9) |
Total net credit risk exposure | 204.9 | 215.2 |
Factor | Description |
| Probability of | The Group has developed PD models tailored to each Term Loan or line of credit product to assess the |
| default (“PD”) | likelihood of default within the next 12 months and over the lifetime. The models estimate PD based on factors |
| including the latest payment behaviour of the customers, commercial, consumer, financial and commercial | |
| credit data sharing (“CCDS”) data points and observed historical trends. The PD model also includes an | |
| estimate of the expected future macroeconomic effect. | |
| Exposure at | The Group has developed an EAD model for line of credit products to assess the likely exposure at default. |
| default (“EAD”) | The model calculates estimates of EAD based upon the latest payment behaviour of the customer, the credit |
| limit utilisation, and projecting expected utilisation at default based on observed historical trends. | |
| Loss given default | The Group has developed LGD models tailored to each Term Loan or line of credit product to assess the likely |
| (“LGD”) | financial loss given an account defaults. The models calculate estimates of LGD based on historical data on |
| observed recoveries against defaulted accounts. | |
Discount rate | The Group uses account-level effective interest rate which is calculated based on line of credit amount or |
| loan amount, interest and fees, expected repayments including prepayments and term. |
Model component | Change since 31 December 2024 |
PD | The PD is now calculated using a model which takes a number of input variables derived from commercial, |
| consumer, financial and behavioural sources of data, which have been observed to correlate with a default. | |
| These inputs are combined to determine a PD curve for each borrower, with 12-month PD utilised for stage 1 | |
| and lifetime PD for stage 2. The marginal PDs are used to calculate an ECL in each respective forward-looking | |
| period. Previously PD was determined using models that utilised the latest payment behaviour of customers | |
| and observed historical trends to project defaults. | |
| Significant | The definition of significant increase in credit risk (“SICR”) used by the Group has been updated to reference |
| increase in | the relative change in the risk score between origination and the balance sheet date. Previously SICR was |
| credit risk | defined as including any account which was overdue or frozen. This change results in a higher proportion of |
| accounts moving to stage 2 prior to becoming late or defaulting, relative to the previous methodology utilised. | |
| The backstop of 30 days past due remains in place. | |
EAD | The EAD methodology has been refined to take account of analysis of the EAD based on more granular |
| utilisation bands for stage 1 and stage 2. This approach has resulted in more accurate EAD prediction when | |
| back tested against actual results across portfolios compared to the less granular credit conversion factor | |
| approach used previously. | |
LGD | The assumptions behind LGD used for FlexiPay have previously been based on the extrapolation of limited |
| actual recovery data given the relatively small levels of defaults on the portfolio to date. The approach has | |
| been refined to supplement data limitations with substantial Term Loan recovery information, in light of a | |
| shared recovery process between the products at a borrower level and as many FlexiPay borrowers also have | |
| Term Loan products, leading to an improved basis for projecting the LGD until more FlexiPay data becomes | |
| available in future. | |
Macro scenarios | The Group’s macro scenarios previously incorporated just unemployment as a forecast variable to take |
| account of forward-looking information. The Group now utilises UK unemployment rates, the risk-free rate | |
| and GDP as the selected forecast variables, with historically observed coefficients between these variables to | |
| predict insolvencies, instead of solely using unemployment rates previously. Further details are provided later | |
| in this note. |
Component | Definition/assumption |
| Significant | The Group assumes there has been a significant increase in credit risk if the probability of default indexed |
| increase in | to the risk score of the borrower has increased over given thresholds since origination and the balance sheet |
| credit risk | date. A backstop is applied for any outstanding amounts on the loan investment which exceed 30 days, in line |
| with the rebuttable presumption per IFRS 9. | |
Forecast period | We estimate PD, EAD and LGD for the duration of the lifetime of the Term Loan or line of credit. Term Loans |
| utilise the contractual term of the Term Loan. For lines of credit, the duration of the lifetime is estimated to be | |
| five years. | |
| Definition | The Group defines a default, classified within non-performing, as a loan investment with any outstanding |
| of default | amounts exceeding 90 days past their due date, which reflects the point at which the loan is considered |
| to be credit impaired. In some circumstances where loans are bought back by the Group, the financial asset | |
| associated with the purchase meets the definition of purchased or originated credit impaired (“POCI”); this | |
| element of the impairment is therefore based on lifetime ECLs. | |
| Lines of credit utilise the same default definition and probability of default under IFRS 9; however, they are | |
| assessed based on 12-month probability of default at the overall available line of credit level, estimating the | |
| expected utilisation of the line of credit at the estimated point of default. The expected credit loss impairment | |
| associated with undrawn lines of credit is disclosed within other liabilities in note 15. |
| Stage 1 | Stage 2 | Stage 3 | |||
| Performing | Underperforming | Non-performing | POCI: | Total | |
| Reconciliation of opening to closing gross carrying amounts | £m | £m | £m | £m | £m |
At 1 January 2024 | 55.8 | 2.0 | 4.3 | 14.7 | 76.8 |
New lending and purchased assets | 467.2 | — | — | — | 467.2 |
Exchange differences | — | — | (0.1) | (0.3) | (0.4) |
Loans transferred between stages | (14.5) | 7.3 | 7.2 | — | — |
Loans repaid | (407.7) | (6.1) | (0.7) | (0.8) | (415.3) |
Written off loans | — | — | — | (0.3) | (0.3) |
Derecognition of assets of discontinued operations | (1.7) | — | (0.3) | (4.7) | (6.7) |
At 31 December 2024 | 99.1 | 3.2 | 10.4 | 8.6 | 121.3 |
New lending and purchased assets | 778.6 | 0.8 | — | 0.9 | 780.3 |
Exchange differences | — | — | — | 0.3 | 0.3 |
Change in SICR definition | (7.2) | 7.2 | — | — | — |
Loans transferred between stages | (25.9) | 15.1 | 10.8 | — | — |
Sale of loans | — | — | — | (4.6) | (4.6) |
Loans repaid | (680.0) | (3.4) | (0.4) | (0.3) | (684.1) |
Written off loans | — | — | (0.4) | (3.7) | (4.1) |
At 31 December 2025 | 164.6 | 22.9 | 20.4 | 1.2 | 209.1 |
| Stage 1 | Stage 2 | Stage 3 | |||
| Performing: | Underperforming: | Non-performing: | POCI: | ||
| 12-month ECL | Lifetime ECL | Lifetime ECL | Lifetime ECL | Total | |
| Reconciliation of opening to closing ECL | £m | £m | £m | £m | £m |
At 1 January 2024 | 1.6 | 1.0 | 3.7 | 13.8 | 20.1 |
Impairment against new lending and purchased assets | 12.7 | — | — | — | 12.7 |
Exchange differences | — | — | (0.1) | (0.3) | (0.4) |
Impairment against loans transferred between stages | (0.2) | 3.9 | 7.1 | — | 10.8 |
Loans repaid | (11.2) | (3.3) | (0.4) | (0.7) | (15.6) |
Impairment provision derecognised related to written off loans | — | — | — | (0.3) | (0.3) |
| Change in probability of default or loss given | (0.1) | (0.2) | (0.8) | 0.6 | (0.5) |
| default assumptions | |||||
Derecognition of impairment associated with assets of discontinued operations | — | — | (0.1) | (4.6) | (4.7) |
At 31 December 2024 | 2.8 | 1.4 | 9.4 | 8.5 | 22.1 |
Impairment against new lending and purchased assets | 21.7 | — | — | 0.6 | 22.3 |
Exchange differences | — | — | — | 0.3 | 0.3 |
Change in SICR definition | (0.2) | 3.3 | — | — | 3.1 |
Impairment against loans transferred between stages | (0.7) | 6.9 | 8.5 | — | 14.7 |
Loans repaid | (19.1) | (1.5) | (0.3) | (0.2) | (21.1) |
Impairment provision derecognised related to written off loans | — | — | (0.3) | (3.8) | (4.1) |
Sale of loans | — | — | — | (4.6) | (4.6) |
| Change in probability of default or loss given | 3.6 | (5.3) | 2.9 | 0.2 | 1.4 |
| default assumptions | |||||
At 31 December 2025 | 8.1 | 4.8 | 20.2 | 1.0 | 34.1 |
| Gross lines | |||||
| of credit and | |||||
| Basis for | SME loans held | Provision for | |||
| Expected credit | recognition of | at amortised | expected | Net carrying | |
| loss coverage | expected credit | cost | credit loss | amount | |
| % | loss impairment | £m | £m | £m | |
| At 31 December 2024 | |||||
Stage 1 – Performing | 2.8 | 12-month ECL | 99.1 | (2.8) | 96.3 |
Stage 2 – Underperforming | 43.8 | Lifetime ECL | 3.2 | (1.4) | 1.8 |
Stage 3 – Non-performing | 90.4 | Lifetime ECL | 10.4 | (9.4) | 1.0 |
POCI | 98.8 | Lifetime ECL | 8.6 | (8.5) | 0.1 |
Total | 121.3 | (22.1) | 99.2 | ||
| At 31 December 2025 | |||||
Stage 1 – Performing | 4.9 | 12-month ECL | 164.6 | (8.1) | 156.5 |
Stage 2 – Underperforming | 21.0 | Lifetime ECL | 22.9 | (4.8) | 18.1 |
Stage 3 – Non-performing | 99.0 | Lifetime ECL | 20.4 | (20.2) | 0.2 |
POCI | 83.3 | Lifetime ECL | 1.2 | (1.0) | 0.2 |
Total | 209.1 | (34.1) | 175.0 |
| Basis for | Provision for | ||||
| Expected credit | recognition of | Gross lines | expected | Net carrying | |
| loss coverage | expected credit | of credit | credit loss | amount | |
| Of which is drawn FlexiPay lines of credit | % | loss impairment | £m | £m | £m |
| At 31 December 2024 | |||||
Stage 1 – Performing | 2.8 | 12-month ECL | 97.0 | (2.7) | 94.3 |
Stage 2 – Underperforming | 43.8 | Lifetime ECL | 3.2 | (1.4) | 1.8 |
Stage 3 – Non-performing | 89.8 | Lifetime ECL | 9.8 | (8.8) | 1.0 |
POCI | — | Lifetime ECL | — | — | — |
Total | 110.0 | (12.9) | 97.1 | ||
| At 31 December 2025 | |||||
Stage 1 – Performing | 4.9 | 12-month ECL | 162.6 | (8.0) | 154.6 |
Stage 2 – Underperforming | 21.0 | Lifetime ECL | 22.9 | (4.8) | 18.1 |
Stage 3 – Non-performing | 99.0 | Lifetime ECL | 19.6 | (19.4) | 0.2 |
POCI | — | Lifetime ECL | — | — | — |
Total | 205.1 | (32.2) | 172.9 |
| Macroeconomic drivers (average | 2026 | 2027 | 2028 | 2029 | 2030 | |
for the forecast year) | ECL scenario | % | % | % | % | % |
Unemployment rates | Base case | 5.0 | 4.8 | 4.5 | 4.4 | 4.2 |
Risk-free rate | Base case | 3.5 | 3.0 | 2.8 | 2.5 | 2.5 |
GDP YoY | Base case | 1.0 | 1.4 | 1.5 | 1.5 | 1.5 |
| Probability weighting applied at | Probability weighting applied at | |
| 31 December 2025 | 31 December 2024 | |
| ECL scenario | % | % |
Base case | 70 | 60 |
Upside | 15 | 10 |
Downside | 15 | 30 |
| Lines of credit net carrying amount | |||||
| 31 December 2025 | |||||
| Stage 1 | Stage 2 | Stage 3 | POCI | Total | |
| Risk banding | £m | £m | £m | £m | £m |
Higher risk banding | 48.7 | 17.4 | 0.2 | — | 66.3 |
Medium risk banding | 51.0 | 0.5 | — | — | 51.5 |
Lower risk banding | 54.9 | 0.2 | — | — | 55.1 |
Total | 154.6 | 18.1 | 0.2 | — | 172.9 |
| Lines of credit net carrying amount | |||||
| 31 December 2024 | |||||
| Stage 1 | Stage 2 | Stage 3 | POCI | Total | |
| Risk banding | £m | £m | £m | £m | £m |
Higher risk banding | 37.6 | 1.3 | 0.5 | — | 39.4 |
Medium risk banding | 27.2 | 0.3 | 0.5 | — | 28.0 |
Lower risk banding | 29.5 | 0.2 | — | — | 29.7 |
Total | 94.3 | 1.8 | 1.0 | — | 97.1 |
| Between | Total | ||||||
| Less than | 3 months and | Between 1 | Over | undiscounted | Impact of | Carrying | |
| 3 months | 1 year | and 5 years | 5 years | cash flows | discounting | amount | |
| At 31 December 2025 | £m | £m | £m | £m | £m | £m | £m |
| Financial liabilities | |||||||
Trade and other payables | (6.7) | — | — | — | (6.7) | — | (6.7) |
Bank borrowings | — | (267.3) | — | — | (267.3) | — | (267.3) |
Lease liabilities | (0.5) | (1.4) | (5.5) | — | (7.4) | 1.1 | (6.3) |
(7.2) | (268.7) | (5.5) | — | (281.4) | 1.1 | (280.3) |
| Between | Total | ||||||
| Less than | 3 months and | Between 1 | Over | undiscounted | Impact of | Carrying | |
| 3 months | 1 year | and 5 years | 5 years | cash flows | discounting | amount | |
| At 31 December 2024 | £m | £m | £m | £m | £m | £m | £m |
| Financial liabilities | |||||||
Trade and other payables | (8.3) | — | — | — | (8.3) | — | (8.3) |
Bank borrowings | — | (101.9) | — | — | (101.9) | — | (101.9) |
Lease liabilities | (0.5) | (1.4) | (7.4) | — | (9.3) | 1.7 | (7.6) |
(8.8) | (103.3) | (7.4) | — | (119.5) | 1.7 | (117.8) |
Less than 3 months | Between 3 months and 1 year | Between 1 and 5 years | ||||
| 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |
| At 31 December | £m | £m | £m | £m | £m | £m |
| Fixed rate | ||||||
SME loans at amortised cost | 0.3 | 0.2 | 0.1 | 0.1 | 1.7 | 1.8 |
Investment in trusts and co-investments | — | — | — | — | 11.9 | 17.8 |
Lines of credit | 52.0 | 42.6 | 96.9 | 47.3 | — | — |
SME loans fair value through profit and loss 1 | 3.4 | 0.7 | 75.0 | — | 42.4 | 0.5 |
| Floating rate | ||||||
Lines of credit 2 | 24.0 | 7.2 | — | — | — | — |
Cash and cash equivalents | 152.4 | 187.6 | — | — | — | — |
Bank borrowings 2 | — | — | (267.3) | (101.9) | — | — |
232.1 | 238.3 | (95.3) | (54.5) | 56.0 | 20.1 |
31 December 2025 | 31 December 2024 | |||||
| GBP | EUR | Total | GBP | EUR | Total | |
| £m | £m | £m | £m | £m | £m | |
Cash and cash equivalents | — | — | — | — | — | — |
Intra-group assets | — | 0.1 | 0.1 | — | 0.1 | 0.1 |
Intra-group liabilities | — | (0.7) | (0.7) | — | (0.5) | (0.5) |
Appreciation in pound sterling | Depreciation in pound sterling | |||||||
| Income | Income | Income | Income | |||||
| statement | Equity | statement | Equity | statement | Equity | statement | Equity | |
| 2025 | 2025 | 2024 | 2024 | 2025 | 2025 | 2024 | 2024 | |
| At 31 December | £m | £m | £m | £m | £m | £m | £m | £m |
US dollars | — | — | — | — | — | — | — | — |
Euros | — | (1.1) | — | (1.0) | — | 0.9 | — | 0.8 |
— | (1.1) | — | (1.0) | — | 0.9 | — | 0.8 |
| 31 December | 31 December | 31 December | 31 December | |
| 2025 | 2025 | 2024 | 2024 | |
| Number | £ | Number | £ | |
| Called up, allotted and fully paid | ||||
Ordinary shares of £0.001 at beginning of the year | 327,935,7 79 | 327,936 | 361,303,143 | 361,303 |
Share buybacks and cancellations | (23,194,203) | (23,194) | (33,367,364) | (33,367) |
Ordinary shares of £0.001 at end of the year | 304,741,576 | 304,742 | 327,9 35 ,779 | 327, 93 6 |
| 2025 | 2024 | |
| £m | £m | |
At 1 January | 0.1 | 293.1 |
Exercise of options – proceeds received | 0.4 | 0.5 |
Capital reduction | — | (293.5) |
At 31 December | 0.5 | 0.1 |
| £m | |
At 1 January 2024 | 14.2 |
Exchange difference on translating the net assets of foreign operations | (0.2) |
Reclassification to profit and loss on disposal of discontinued operations | (8.7) |
At 31 December 2024 | 5.3 |
Exchange difference on translating the net assets of foreign operations | — |
At 31 December 2025 | 5.3 |
| £m | |
At 1 January 2024 | (84.9) |
Transfer of share option costs | 6.6 |
Buyback of own shares | (33.6) |
Capital reduction | 293.5 |
Loss for the year | 8.6 |
At 31 December 2024 | 190.2 |
Transfer of share option costs | 4.2 |
Buyback of own shares | (30.6) |
Purchase of own shares by EBT | (8.6) |
Capital reduction | — |
Loss for the year | 46.0 |
At 31 December 2025 | 201.2 |
| Free shares | ||||||||||||
| Unapproved | and matching | US Options | ||||||||||
| EMI Options | Options | shares | LTIP Awards | Schemes | Total | |||||||
Number and WAEP 1 | Number and WAEP | Number and WAEP | Number and WAEP | Number and WAEP | Number and WAEP | |||||||
Number | £m | Number | £m | Number | £m | Number | £m | Number | £m | Number | £m | |
| Outstanding | 45,300 | 0.024 | 4,622,591 | 0.328 | 4,392,634 | — | 33,540,539 | — | 2,772,350 | 0.429 | 45,373,414 | 0.068 |
| at 1 January | ||||||||||||
| 2024 | ||||||||||||
| Granted | — | — | — | — | 469,010 | — | 12,313,814 | — | — | — | 12,782,824 | — |
during the year | ||||||||||||
| Exercised | (45,300) | 0.024 | (951,535) | 0.360 | (826,552) | — | (6,733,720) | — | (741,224) | 0.294 | (9,298,331) | 0.061 |
during the year | ||||||||||||
| Forfeited | — | — | (141) | 0.440 | (717,4 80) | — | (13,159,091) | — | (16,093) | 0.245 | (13,892,805) | — |
during the year | ||||||||||||
| Outstanding | — | — | 3,670,915 | 0.319 | 3,317,612 | — | 25,961,542 | — | 2,015,033 | 0.480 | 34,965,102 | 0.072 |
| at 31 | ||||||||||||
| December | ||||||||||||
| 2024 | ||||||||||||
| Free shares | ||||||||||||
| Unapproved | and matching | US Options | ||||||||||
| PSP Options | Options | shares | LTIP Awards | Schemes | Total | |||||||
Number and WAEP 1 | Number and WAEP | Number and WAEP | Number and WAEP | Number and WAEP | Number and WAEP | |||||||
Number | £m | Number | £m | Number | £m | Number | £m | Number | £m | Number | £m | |
| Outstanding | — | — | 3,670,915 | 0.319 | 3,317,612 | — | 25,961,542 | — | 2,015,033 | 0.480 | 34,965,102 | 0.072 |
| at 1 January | ||||||||||||
| 2025 | ||||||||||||
| Granted | 5,775,755 | — | — | — | 240,290 | — | 3,920,954 | — | — | — | 9,936,999 | — |
during the year | ||||||||||||
| Exercised | — | — | (207,251) | 0.318 | (638,215) | — | (4,584,403) | — | (1,182,312) | 0.301 | (6,612,181) | 0.060 |
during the year | ||||||||||||
| Forfeited | (365,337) | — | (61,171) | 0.284 | (302,528) | — | (4,345,118) | — | (13,975) | 0.440 | (5,088,129) | 0.005 |
during the year | ||||||||||||
| Outstanding | 5,410,418 | — | 3,402,493 | 0.320 | 2,617,159 | — | 20,952,975 | — | 818,746 | 0.740 | 33,201,791 | 0.062 |
| at 31 | ||||||||||||
| December | ||||||||||||
| 2025 | ||||||||||||
| Free shares | ||||||||||||
| Unapproved | and matching | US Options | ||||||||||
| PSP Options | Options | shares | LTIP Awards | Schemes | Total | |||||||
Range of exercise | Number and | WARCL 1 | Number and WARCL | Number and WARCL | Number and WARCL | Number and WARCL | Number and WARCL | |||||
| prices | Number | Years | Years | Number | Years | Number | Years | Number | Number | Years | Years | Number |
£0–£0.008 | 5,410,418 | 9.5 | 2.5 | 2,153,314 | — | 2,617,1 59 | 7.5 | 20,952,975 | — | — | 6.8 | 31,119,891 |
£0.009–£0.176 | — | — | — | — | — | — | — | — | — | — | — | — |
£0.177–£0.471 | — | — | 1.8 | 879,203 | — | — | — | — | 261,435 | 2.5 | 1.9 | 1,154,613 |
| £0.472–£1.75 | — | — | 2.4 | 369,976 | — | — | — | — | 557,311 | 2.6 | 2.5 | 927,287 |
5,410,418 | 9.5 | 2.3 | 3,402,493 | — | 2,617,159 | 7.5 | 20,952,975 | 818,746 | 2.5 | 6.6 | 33,201,791 | |
| Free shares | ||||||||||||
| Unapproved | and matching | US Options | ||||||||||
| EMI Options | Options | shares | LTIP Awards | Schemes | Total | |||||||
| Number and | ||||||||||||
Range of exercise | WARCL 1 | Number and WARCL | Number and WARCL | Number and WARCL | Number and WARCL | Number and WARCL | ||||||
| prices | Number | Years | Years | Number | Years | Number | Years | Number | Number | Years | Years | Number |
£0–£0.008 | — | — | 3.4 | 2,190,017 | — | 3,317,612 | 8.0 | 25,961,542 | — | — | 6.8 | 31,469,171 |
£0.009–£0.176 | — | — | — | 2,033 | — | — | — | — | — | — | — | 2,033 |
£0.177–£0.471 | — | — | 2.6 | 1,110,227 | — | — | — | — | 1,417,6 50 | 0.9 | 1.7 | 2,527,877 |
| £0.472–£1.75 | — | — | 3.4 | 368,638 | — | — | — | — | 597,38 3 | 3.4 | 3.4 | 966,021 |
— | — | 3.2 | 3,670,915 | — | 3,317,612 | 8.0 | 25,961,542 | 2,015,033 | 1.7 | 6.4 | 34,965,102 | |
| 31 December | |
| Unapproved Options Scheme | 2019 |
Share price (various times during the year) | £1.89 |
Exercise price | £nil–£0.44 |
Expected life | 4 years |
Expected volatility | 48% |
Risk-free interest rate (between) | 0.93%–1.02% |
Dividend yield | Nil |
Forward exchange rate – US Options (between) | 0.769 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
| Profit before taxation | ||
Continuing operations | 20.3 | 0.8 |
Discontinued operations | — | 8.4 |
Total operations | 20.3 | 9.2 |
| Adjustments for: | ||
Depreciation of property, plant and equipment | 2.3 | 3.2 |
Amortisation of intangible assets | 8.7 | 9.8 |
Modification gain | — | (0.4) |
| Impairment of property, plant and equipment, intangible assets, ROU assets and investment | 0.1 | 0.9 |
| in sublease | ||
Impairment of intangibles (exceptional item) | — | 0.3 |
Interest payable | 0.6 | 0.8 |
| Non-cash employee benefits expense – share-based payments and associated | 5.0 | 8.1 |
| social security costs | ||
Fair value adjustments | 6.7 | (6.4) |
Movement in loan repurchase liability | — | (0.1) |
Movement in other provisions | (1.1) | 1.7 |
Share of gains of associates | — | — |
ECL impairment | 18.3 | 8.7 |
Profit on sale of the US subsidiary (exceptional item) | — | (9.8) |
Recycling of foreign exchange reserve on sale of subsidiary (exceptional item) | — | (8.7) |
Other non-cash movements | 1.4 | (0.2) |
| Changes in working capital | ||
Movement in trade and other receivables | (11.4) | (3.1) |
Movement in trade and other payables | 2.5 | (26.6) |
Tax received/(paid) | 2.1 | (0.1) |
Originations of lines of credit | (771.4) | (467.0) |
Cash receipts from lines of credit | 682.1 | 412.3 |
Net cash outflow from operating activities | (33.8) | (67.4) |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Cash and cash equivalents | 152.4 | 187.6 |
| Derecognition | ||||||
| of liabilities | ||||||
| related to | ||||||
| 1 January | Exchange | Other non-cash | discontinued | 31 December | ||
| 2024 | Cash flow | movements | movements | operations | 2024 | |
| £m | £m | £m | £m | £m | £m | |
Bank borrowings | (56.9) | (46.6) | — | — | 1.6 | (101.9) |
Lease liabilities | (12.6) | 3.6 | (0.3) | (5.8) | 7.5 | (7.6) |
Liabilities from financing activities | (69.5) | (43.0) | (0.3) | (5.8) | 9.1 | (109.5) |
| Derecognition | ||||||
| of liabilities | ||||||
| related to | ||||||
| 1 January | Exchange | Other non-cash | discontinued | 31 December | ||
| 2025 | Cash flow | movements | movements | operations | 2025 | |
| £m | £m | £m | £m | £m | £m | |
Bank borrowings | (101.9) | (165.4) | — | — | — | (267.3) |
Lease liabilities | (7.6) | 1.9 | — | (0.6) | — | (6.3) |
Liabilities from financing activities | (109.5) | (163.5) | — | (0.6) | — | (273.6) |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Lease payments under operating leases recognised as an expense in the year 1 | — | 0.2 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Salaries and short-term benefits | 5.3 | 5.0 |
Equity-based compensation | 2.4 | 1.3 |
Post-employment benefits | 0.1 | 0.1 |
7.8 | 6.4 |
| Place of | ||||
| incorporation | ||||
| and principal | Proportion of | Directly/ | ||
| place of | ownership | indirectly | ||
| Subsidiary undertakings | business | interest | held | Registered office address |
Funding Circle Ltd | UK | 100% | Directly | 71 Queen Victoria Street, London EC4V 4AY |
Funding Circle BB Limited | UK | 100% | Indirectly | 71 Queen Victoria Street, London EC4V 4AY |
Funding Circle Eclipse Lending Limited | UK | 100% | Indirectly | 71 Queen Victoria Street, London EC4V 4AY |
| Funding Circle Focal Point Lending | UK | 100% | Indirectly | 71 Queen Victoria Street, London EC4V 4AY |
| Limited | ||||
Funding Circle Global Partners Limited | UK | 100% | Directly | 71 Queen Victoria Street, London EC4V 4AY |
Funding Circle Trustee Limited | UK | 100% | Indirectly | 71 Queen Victoria Street, London EC4V 4AY |
Made To Do More Limited | UK | 100% | Indirectly | 71 Queen Victoria Street, London EC4V 4AY |
Funding Circle Polaris Lending Limited | UK | 100% | Indirectly | 71 Queen Victoria Street, London EC4V 4AY |
Funding Circle CE GmbH | Germany | 100% | Directly | Rheinstraße 11, 14513 Teltow |
Funding Circle Deutschland GmbH | Germany | 100% | Indirectly | Rheinstraße 11, 14513 Teltow |
Funding Circle Connect GmbH | Germany | 100% | Indirectly | Rheinstraße 11, 14513 Teltow |
FC Forderungsmanagement GmbH | Germany | 100% | Indirectly | Rheinstraße 11, 14513 Teltow |
Funding Circle Nederland B.V. | Netherlands | 100% | Indirectly | 71 Queen Victoria Street, London EC4V 4AY |
| Proportion of | Directly/ | |||
| Place of | ownership | indirectly | ||
| Associate entity name | incorporation | interest | held | Registered office address |
Funding Circle UK SME Direct Lending Fund¹ | Ireland | 8% | Indirectly | 70, Sir John Rogerson’s Quay, Dublin 2, Ireland |
| Proportion of | Directly/ | ||||
| Place of | ownership | indirectly | |||
| Other related party name | incorporation | Relationship | interest | held | Registered office address |
| Throgmorton Lending Designated | Ireland | Subsidiary | 100% | Indirectly | 70, Sir John Rogerson’s Quay, |
| Activity Company | of associate | Dublin 2, Ireland |
| Funding Circle | Funding Circle | |
| UK SME Direct | UK SME Direct | |
| Lending Fund I | Lending Fund I | |
| 31 December | 31 December | |
| 2025 | 2024 | |
| Summarised balance sheet (Group’s share) | £m | £m |
Non-current assets | — | 0.4 |
Current assets | 0.2 | 0.2 |
Current liabilities | (0.2) | — |
Non-current liabilities | — | — |
Net assets | — | 0.6 |
| Funding Circle | Funding Circle | |
| UK SME Direct | UK SME Direct | |
| Lending Fund I | Lending Fund I | |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £m | £m | |
Opening net assets as at 1 January | 7.2 | 18.3 |
(Loss)/profit for the year | (0.4) | 0.4 |
Capital redemptions in the year | (6.8) | (11.1) |
Dividends paid in the year | — | (0.4) |
Closing net assets as at 31 December | — | 7.2 |
Group’s share in % | 8.3% | 8.3% |
Group’s share of net assets as at 31 December | — | 0.6 |
Accounting policy alignment | — | — |
Group’s carrying amount | — | 0.6 |
| Funding Circle | Funding Circle | |
| UK SME Direct | UK SME Direct | |
| Lending Fund I | Lending Fund I | |
| 31 December | 31 December | |
| 2025 | 2024 | |
| Summarised statement of comprehensive income (Group’s share) | £m | £m |
Gross income | — | 0.1 |
(Loss)/profit for the year | — | — |
Other comprehensive income | — | — |
Total comprehensive income | — | — |
Dividends received from associates | — | — |
Capital redemptions received from associates | 0.6 | 0.9 |
Subsidiary undertakings | Principal activity |
Funding Circle Ltd | Acts as facilitator and performs intermediary services in respect of all loans made |
| through the Funding Circle platform in the UK and FlexiPay lines of credit. | |
| Funding Circle Focal Point Lending | Subsidiary via which CBILS loans are originated and which holds legal title to loans |
| Limited | which are held via trust structures for the beneficial ownership of institutional investors. |
| Funding Circle Eclipse Lending | Subsidiary via which RLS loans are originated and which holds legal title to loans which |
| Limited | are held via trust structures for the beneficial ownership of institutional investors. |
| Funding Circle Polaris Lending | Subsidiary via which RLS and GGS loans are originated and which holds legal title to loans |
| Limited | which are held via trust structures for the beneficial ownership of institutional investors. |
Funding Circle Deutschland GmbH | Operated the Funding Circle platform in Germany and services loans. |
Funding Circle Nederland B.V. | Operated the Funding Circle platform in the Netherlands and services loans. |